ST. LOUIS and MOORESTOWN, N.J., April 04, 2018 -- Capstone Performance Systems, a subsidiary of Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), today announced that George “Mike” Brett, MD, has been named Senior Vice President of Consulting. Dr. Brett, who retains his title of Chief Medical Officer for Capstone, will oversee Capstone’s new Consulting Services team. Capstone Performance Systems provides expert Medicare risk adjustment services to Programs of All-Inclusive Care for the Elderly (PACE) and similar healthcare organizations to ensure proper reimbursement and optimal utilization of services and funds.
|
|||
“As our physician lead, Dr. Brett enjoys broad admiration from Capstone clients, because of his unique skills in making clinical documentation excellence training relevant, achievable and enjoyable,” said Richard Schamp, MD, CEO of Capstone Performance Systems. “We are confident Dr. Brett will provide the leadership and energy to advance our Consulting Services team and serve the mounting needs of the market.”
Capstone Performance Systems continues to expand its presence in both the PACE and non-PACE markets. As US healthcare moves increasingly toward risk-adjusted payment models, the company has evolved its organizational infrastructure to serve its growing market. “Our physician client base nearly doubled in 2017, and we are training nearly 400 physicians in more than 60 organizations from coast to coast,” Dr. Schamp continued. “To meet this demand, we tapped Dr. Brett to lead our Consulting Services team, which uses both technology and human expertise to address our clients’ needs for scalability.”
Dr. Brett has more than 30 years of experience in geriatric medicine and long-term care. Prior to joining Capstone Performance Systems in 2014, he served as the medical director for LIFE programs at Lutheran Senior Life in Western Pennsylvania. LIFE (Living Independence for the Elderly) is part of the National PACE Program. Dr. Brett was also in private practice specializing in internal medicine and geriatrics. He is a frequent presenter on topics including polypharmacy in the elderly and risk adjustment.
About Capstone Performance Systems
Capstone Performance Systems specializes in helping organizations adjust processes and systems to capture timely, complete and accurate data. Expert staff deliver provider-to-provider/staff training in documentation and diagnosis coding; analyze data collection and submission processes; and deliver meaningful analytics for understanding the complexities of Medicare risk adjustment. Managing Medicare risk scores can have a significant impact on an organization’s performance and revenue. Capstone is a Tabula Rasa HealthCare company. For more information, visit www.CapstonePerformanceSystems.com.
About Tabula Rasa HealthCare
Tabula Rasa HealthCare (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. Medication risk management is TRHC’s lead offering, and its cloud-based software applications provide solutions for a range of payers, providers and other healthcare organizations. For more information, visit www.TRHC.com.
Forward-Looking Statements
This press release includes forward-looking statements that we believe to be reasonable as of today’s date. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; and the other risk factors set forth from time to time in our filings with the SEC, including those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, filed with the SEC on March 14, 2018, and in subsequent reports filed with or furnished to the SEC, copies of which are available free of charge within the Investor Relations section of the TRHC website http://ir.trhc.com or upon request from our Investor Relations Department. Any forward-looking statement speaks only as of the date on which it was made. TRHC assumes no obligation and does not intend to update these forward-looking statements, except as required by law, to reflect events or circumstances occurring after today’s date.
Media Contact
Carla Davenport
[email protected]
T: (856) 208-4604


Meta Cuts Wipro Outsourcing by 25% After AI-Led Restructuring
Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says
Telegram Restored on Apple App Store After Temporary Removal
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Capital One Says AML Review Led to Closure of Trump Organization Accounts
Bayer Q2 Earnings Beat Forecasts as Crop Science Boosts Results, Debt Outlook Improves
Roblox Stock Drops 16% as Q3 Bookings Forecast Misses Expectations
Toyota Raises FY2027 Outlook, Announces ¥1 Trillion Buyback Despite Q1 Profit Dip
Vast Eyes Hong Kong IPO as Chinese AI Unicorn Gains Momentum
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion
Palantir Stock Soars as AI Demand Drives Strong Q2 Earnings and Higher 2026 Outlook
Trump Urges Exxon, Chevron to Cut Gas Prices After Record Oil Profits
Chery Invests $75 Million in KG Mobility to Expand Global Automotive Partnership
FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners
HSBC H1 Profit Jumps 23%, Announces $1 Billion Share Buyback and Reaffirms 2028 Targets
Shein Targets $30B-$40B Valuation in Hong Kong IPO Planned for August 



